Document ID: chunk:federal_register_of_legislation:F2021L00026:reg:9:p3
Version: federal_register_of_legislation:F2021L00026
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9398–11817

Note: extrinsic aural device is defined in the Schedule 1 - Dictionary.
(20)      having an acquired, persistent narrowing or obstruction of the external auditory canal of the affected ear at the time of the clinical worsening of otitis externa;
Note 1: Examples of causes of narrowing or obstruction of the external auditory canal include:
                (a) benign or malignant neoplasm;
                (b) cerumen accumulation;
                (c) exostosis of the external auditory canal; and
                (d) granuloma.
Note 2: exostosis of the external auditory canal is defined in the Schedule 1 - Dictionary.
(21)      having an inflammatory skin disease at the time of the clinical worsening of otitis externa, where the skin disease involves the external auditory canal of the affected ear;
            Note 1: Examples of an inflammatory skin disease include allergic or irritant contact dermatitis, seborrhoeic dermatitis, lichen planus, psoriasis and eczema.
            Note 2: Irritant or allergic contact dermatitis of the external auditory canal may be caused by shampoos, ototopical medications or accidental chemical splashes to the ear.
(22)      having an infectious, autoimmune or granulomatous disease at the time of the clinical worsening of otitis externa, where the disease involves the external auditory canal of the affected ear;
            Note: Examples of an infectious, autoimmune or granulomatous disease include herpes zoster, relapsing polychondritis and sarcoidosis.
(23)      having chronic suppurative otitis media, involving the middle ear of the affected side, within the 30 days before the clinical worsening of otitis externa;
Note: chronic suppurative otitis media is defined in the Schedule 1 - Dictionary.
(24)      having diabetes mellitus at the time of the clinical worsening of otitis externa;
(25)      being in an immunocompromised state as specified at the time of the clinical worsening of otitis externa;
Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.
(26)      for otomycosis only, taking a course of oral antibiotic therapy or having ototopical therapy for the treatment of otitis externa of the affected ear within the 30 days before the clinical worsening of otitis externa;
Note: otomycosis is defined in the Schedule 1 - Dictionary.
(27)      inability to obtain appropriate clinical management for otitis externa.